TRENTON, N.J. - A federal appeals court has revived a multibillion Medicare fraud case brought by whistle-blowers alleging Johnson & Johnson paid doctors kickbacks to prescribe an expensive drug to boost sales.
Two former salespeople for the health care giant have alleged that J&J’s Ortho Biotech Products unit, which sells the anemia drug Procrit, gave doctors kickbacks to write prescriptions for the blockbuster drug during the 1990s. Most of the prescriptions were covered by the federal Medicare program.
Jan Schlichtmann, attorney for the former salesmen, said Ortho Biotech ran “an extensive scheme’’ in which doctors were given free Procrit, honoraria, speaking fees, “off-the-invoice discounts,’’ and other monetary inducements to give their patients Procrit, particularly after the drug faced competition from rival Amgen Inc.’s Aranesp.
READER COMMENTS »
View reader comments » Comment on this story »